Israel - English - Ministry of Health

pharma shalom - mizolastine - film coated tablets - mizolastine 10 mg - mizolastine - mizolastine - symptomatic treatment of seasonal allergic rhinoconjuctivitis (hay fever), perennial allergic rhino-conjuctivitis and urticaria.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

opella healthcare belgium sa-nv - mizolastine 10 mg - modified-release tablet - 10 mg - mizolastine 10 mg - mizolastine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi consumer healthcare - mizolastine - modified-release tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

galderma (uk) ltd - mizolastine - modified-release tablet - 10mg

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - itraconazole 10 mg/ml - oral solution - 10 mg/ml - active: itraconazole 10 mg/ml excipient: caramel cherry flavour 654536 cherry flavour 654595 hydrochloric acid hydroxypropyl-beta-cyclodextrin propylene glycol purified water saccharin sodium sodium hydroxide sorbitol - sporanox oral solution is indicated for the: · treatment of oral and/or oesophageal candidiasis in hiv-positive or other immunocompromised patients. · prophylaxis of fungal infections in neutropenic patients.

Namibia - English - Namibia Medicines Regulatory Council

adcock ingram limited - mizolastine - tablets - each film -coated modified release tablet contains mizolastine 10 mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

opella healthcare belgium sa-nv - mizolastine 10 mg - modified-release tablet - mizolastine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

opella healthcare belgium sa-nv - mizolastine 10 mg - modified-release tablet - mizolastine

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - itraconazole, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; hydroxypropylbetadex; saccharin sodium; purified water; caramel; sorbitol solution (70 per cent) (non-crystallising); sodium hydroxide; hydrochloric acid; flavour - sporanox oral solution is indicated for: * the treatment of oral and/or oesophageal candidiasis in hiv-positive or other immunocompromised patients. * prophylaxis of fungal infections in neutropenic patients.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson pte. ltd. - domperidone - tablet, film coated - 10 mg - domperidone 10 mg